- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
The Weekly Roundup: December 9-13
Author(s):
Key Takeaways
- Coaches need better education on UV risks to protect athletes from sun exposure during outdoor sports.
- VYC-17.5 L is effective and safe for reducing marionette lines, with high satisfaction among clinicians and participants.
In case you missed it, this week we had news about the 308 nm excimer light and 2940 erbium laser for vitiligo, the new Diamond technique for the neck and décolleté, potential risk factors for developing CHE in China, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
UV and Outdoor Sports: The Importance of Coaches in Educating Athletes
Despite the risks of sun exposure, a study found only a fraction of coaches receive adequate UV-related guidance from their associations or clubs.
Catch up on exclusive interviews with Shanna Miranti, MPAS, PA-C; Renata Block, MMS, PA-C; Jane Mast, PhD, DMSc, MPAS; PA-C; Sara Wilchowski, DMSc, MPAS, PA-C; and Michael Rubio, PA-C, from the 2024 SDPA Fall Conference.
VYC-17.5 L Can Improve Marionette Lines, According to Recent Study
With high clinician and participant satisfaction ratings, VYC-17.5 L was found to be safe and effective in reducing the appearance of marionette lines.
“ARM Yourself with Knowledge": Emmy Graber, MD, MBA, Shares Insights on Acne, Rosacea, and More
Graber spoke with Dermatology Times to share the top clinical pearls and key takeaways from the recent meetings.
Closing the Chapter on a Booming Year of Dermatology
A reflection on 2024's dermatology advancements, from FDA approvals to expert insights, setting the stage for another transformative year in 2025.
Looking Back at Highlights From 2024 PA & NP Conferences
Review some of the top highlights shared at physician assistant and nurse practitioner dermatology meetings in 2024.
A Family-Centered Approach to Managing AD
The review found AD can disrupt family life, as caregiving responsibilities can lead to stress, guilt, and reduced opportunities for shared activities.
Several Risk Factors, Including PAE, Associated with Acne Scarring in Thai Patients
Researchers noted higher correlations in those who are prone to severe acne and post acne erythema (PAE).
Letter From the Editor: Embrace Your Story
Fall Editor in Chief Raj Chovatiya, MD, PhD, MSCI, celebrates the joy of diverse traditions and reflects on the path to equity in dermatology as we move toward a brighter 2025.
Psoriasis Patients Without Insurance Are More Likely Unable to Obtain Care
The effect of insurance status on US patients with psoriasis can help identify those at risk of being undertreated.
Deucravacitinib Improves Psoriasis Symptoms in Japanese Patients
Researchers found two-thirds of patients reported no impact of psoriasis on their quality of life after 52 weeks of treatment with deucravacitinib.
New Diamond Technique Introduced for Neck and Décolleté Rejuvenation
Although further trials are needed, this multidimensional, minimally invasive approach showed positive results in 4 patients.
2024 Breakthroughs in Skin Cancer
Discover 2024 skin cancer breakthroughs, including FDA approvals, innovative therapies, and updated clinical guidelines for melanoma and nonmelanoma care.
2024 saw significant progress in vitiligo treatments, including novel drugs, off-label uses, and updated pediatric guidelines for better outcomes.
Researchers Identify Potential Risk Factors of CHE in General Chinese Population
The study found that those who worked with wet hands and had chapped skin had a higher severity of chronic hand eczema.
Patients with Rosacea are More Likely to Develop Anxiety and Depression
In Middle Eastern communities specifically, patients with higher disease severity and duration are predicted to have poorer psychological outcomes.
Excimer Light and Erbium Laser: A Dual Solution for Vitiligo
Researchers emphasized the need for future studies to refine protocols and address economic barriers to combination therapy.
SB5 is Effective and Safe for Long-Term Psoriasis Treatment
The adalimumab biosimilar had an average persistence of 2.5 years, according to this British study.
Pediatric and Adult AD Cases Illuminate Benefits of Topical PDE4 Inhibitors
Swanson and Lockshin explored how PDE4 inhibitors improve quality of life for AD patients through targeted treatments that address both inflammation and chronic symptoms.
Join Dermatology Times’ quarterly editor in chief Shanna Miranti, MPAS, PA-C, in a look back at acne milestones in 2024 such as topical clindamycin, adapalene, and benzoyl peroxide gel (Cabtreo).
Triple-Frequency Ultrasound Proven to Be Effective in Reducing Cellulite
Frequencies of 1/3/10 MHz and 3/10/19 MHz provided pain-free, well-tolerated, and long-lasting results.
Aesthetic Implications of GLP-1 Agonists
A recent review recognized the aesthetic concerns associated with GLP-1-induced weight loss and noted treatment options for various challenges.
Dermatology Times’ quarterly editor in chief Christopher Bunick, MD, PhD, discussed transformative advances in psoriasis care.
2024 Key Insights: Atopic Dermatitis
Dermatology Times’ quarterly editor in chief Raj Chovatiya, MD, PhD, MSCI, reviewed key updates in atopic dermatitis.
